Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on N Substituted Amino Acid Ester. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel one-pot method replaces Pd catalysis for EGFR inhibitor intermediates, offering cost-effective scale-up and high purity for pharma supply chains.
Patent CN101880241A reveals a safer one-pot Curtius rearrangement for Candesartan intermediates, offering significant cost reduction and supply chain reliability for API manufacturers.
Novel Pd/C catalytic method ensures high purity and yield. Reduces steps for pharmaceutical intermediate manufacturing. Reliable supply chain partner.